Brief: Vistagen Broadens PH80 Global Intellectual Property Portfolio With New Patents For The Treatment Of Migraine
09/07/2024 13:49
July 9 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* VISTAGEN BROADENS PH80 GLOBAL INTELLECTUAL PROPERTY
PORTFOLIO
WITH NEW PATENTS FOR THE TREATMENT OF MIGRAINE
* VISTAGEN THERAPEUTICS INC: ALL OF NEW PATENTS ARE EXPECTED
TO BE
IN EFFECT UNTIL 2040
Source text for Eikon: ID:nBw93kr3ga
Further company coverage: VTGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors